- Home
- PALI vs RMR Comparison
PALI vs RMR Comparison
Compare PALI & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PALI | RMR |
|---|---|---|
| Founded | 1996 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.7M | 341.0M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PALI | RMR |
|---|---|---|
| Price | $1.95 | $20.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $11.29 | ★ $19.00 |
| AVG Volume (30 Days) | ★ 2.5M | 131.9K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.37% |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ 0.77 |
| Revenue | $260,000.00 | ★ $700,284,000.00 |
| Revenue This Year | N/A | $259.61 |
| Revenue Next Year | N/A | $2.45 |
| P/E Ratio | ★ N/A | $26.94 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $14.27 |
| 52 Week High | $2.86 | $21.45 |
Technical Indicators
Market Signals| Indicator | PALI | RMR |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 60.32 |
| Support Level | $1.57 | $19.74 |
| Resistance Level | $2.12 | $21.45 |
| Average True Range (ATR) | 0.14 | 0.47 |
| MACD | 0.02 | -0.09 |
| Stochastic Oscillator | 75.00 | 53.47 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company with a primary focus on commercial real estate and related businesses in the United States. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. The company manages a diverse portfolio of real estate assets across sectors such as office, industrial, healthcare, retail, and hospitality, etc. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company derives the majority of its revenues from its provision of management services.